TABLE OF CONTENTS
1 INTRODUCTION 62
1.1 OBJECTIVES OF THE STUDY 62
1.2 MARKET DEFINITION 62
1.3 OVERVIEW OF U.S. (STATE-BY-STATE ANALYSIS) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET 62
1.4 LIMITATIONS 64
1.5 MARKETS COVERED 64
2 MARKET SEGMENTATION 67
2.1 MARKETS COVERED 67
2.2 GEOGRAPHICAL SCOPE 68
2.3 YEARS CONSIDERED FOR THE STUDY 68
2.4 CURRENCY AND PRICING 68
2.5 DBMR TRIPOD DATA VALIDATION MODEL 69
2.6 MULTIVARIATE MODELLING 72
2.7 FOOD TYPE LIFELINE CURVE 72
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 73
2.9 DBMR MARKET POSITION GRID 74
2.10 MARKET END USER COVERAGE GRID 75
2.11 SECONDARY SOURCES 76
2.12 ASSUMPTIONS 76
3 EXECUTIVE SUMMARY 77
4 PREMIUM INSIGHTS 80
4.1 PESTEL ANALYSIS 81
4.2 PORTER'S 5 FORCES 82
4.3 PRODUCT PRICE ANALYSIS (2019-2030) 83
4.3.1 NEW YORK PRODUCT PRICE ANALYSIS -(2019-2030) 83
4.3.2 MASSACHUSETTS PRODUCT PRICE ANALYSIS -(2019-2030) 85
4.3.3 WASHINGTON PRODUCT PRICE ANALYSIS (2019-2030) 87
4.3.4 CONNECTICUT PRODUCT PRICE ANALYSIS (2019-2030) 89
4.3.5 CALIFORNIA PRODUCT PRICE ANALYSIS (2019-2030) 91
4.3.6 DELAWARE PRODUCT PRICE ANALYSIS (2019-2030) 93
4.3.7 ILLINOIS PRODUCT PRICE ANALYSIS (2019-2030) 95
4.3.8 ALASKA PRODUCT PRICE ANALYSIS (2019-2030) 97
4.3.9 MARYLAND PRODUCT PRICE ANALYSIS (2019-2030) 99
4.3.10 NORTH DAKOTA PRODUCT PRICE ANALYSIS (2019-2030) 101
4.3.11 NEW JERSEY PRODUCT PRICE ANALYSIS (2019-2030) 103
4.3.12 COLORADO PRODUCT PRICE ANALYSIS (2019-2030) 105
4.3.13 MINNESOTA PRODUCT PRICE ANALYSIS (2019-2030) 107
4.3.14 NEBRASKA PRODUCT PRICE ANALYSIS (2019-2030) 109
4.3.15 VIRGINIA PRODUCT PRICE ANALYSIS (2019-2030) 111
4.3.16 WYOMING PRODUCT PRICE ANALYSIS (2019-2030) 113
4.3.17 NEW HAMPSHIRE PRODUCT PRICE ANALYSIS (2019-2030) 115
4.3.18 SOUTH DAKOTA PRODUCT PRICE ANALYSIS (2019-2030) 117
4.3.19 HAWAII PRODUCT PRICE ANALYSIS (2019-2030) 119
4.3.20 LOWA PRODUCT PRICE ANALYSIS (2019-2030) 121
4.3.21 PENNSYLVANIA PRODUCT PRICE ANALYSIS (2019-2030) 123
4.3.22 KANSAS PRODUCT PRICE ANALYSIS (2019-2030) 125
4.3.23 TEXAS PRODUCT PRICE ANALYSIS (2019-2030) 127
4.3.24 OREGON PRODUCT PRICE ANALYSIS (2019-2030) 129
4.3.25 UTAH PRODUCT PRICE ANALYSIS (2019-2030) 131
4.3.26 WISCONSIN PRODUCT PRICE ANALYSIS (2019-2030) 133
4.3.27 OHIO PRODUCT PRICE ANALYSIS (2019-2030) 135
4.3.28 GEORGIA PRODUCT PRICE ANALYSIS (2019-2030) 137
4.3.29 NORTH CAROLINA PRODUCT PRICE ANALYSIS (2019-2030) 139
4.3.30 INDIANA PRODUCT PRICE ANALYSIS (2019-2030) 141
4.3.31 RHODE ISLAND PRODUCT PRICE ANALYSIS (2019-2030) 143
4.3.32 NEVADA PRODUCT PRICE ANALYSIS (2019-2030) 145
4.3.33 MISSOURI PRODUCT PRICE ANALYSIS (2019-2030) 147
4.3.34 TENNESSEE PRODUCT PRICE ANALYSIS (2019-2030) 149
4.3.35 LOUISIANA PRODUCT PRICE ANALYSIS (2019-2030) 151
4.3.36 MICHIGAN PRODUCT PRICE ANALYSIS (2019-2030) 153
4.3.37 VERMONT PRODUCT PRICE ANALYSIS (2019-2030) 155
4.3.38 ARIZONA PRODUCT PRICE ANALYSIS (2019-2030) 157
4.3.39 FLORIDA PRODUCT PRICE ANALYSIS (2019-2030) 159
4.3.40 MAINE PRODUCT PRICE ANALYSIS (2019-2030) 161
4.3.41 NEW MEXICO PRODUCT PRICE ANALYSIS (2019-2030) 163
4.3.42 KENTUCKY PRODUCT PRICE ANALYSIS (2019-2030) 165
4.3.43 MONTANA PRODUCT PRICE ANALYSIS (2019-2030) 167
4.3.44 SOUTH CAROLINA PRODUCT PRICE ANALYSIS (2019-2030) 169
4.3.45 OKLAHOMA PRODUCT PRICE ANALYSIS (2019-2030) 171
4.3.46 ALABAMA PRODUCT PRICE ANALYSIS (2019-2030) 173
4.3.47 IDAHO PRODUCT PRICE ANALYSIS (2019-2030) 175
4.3.48 ARKANSAS PRODUCT PRICE ANALYSIS (2019-2030) 177
4.3.49 WEST VIRGINIA PRODUCT PRICE ANALYSIS (2019-2030) 179
4.3.50 MISSISSIPPI PRODUCT PRICE ANALYSIS (2019-2030) 181
4.4 GROWTH STRATEGIES - 183
4.5 REIMBURSEMENT SCENARIO - 184
4.6 LIST OF PHARMACEUTICAL COMPANIES HAVING ANTI-FOOD ALLERGY DRUGS PORTFOLIO 186
4.7 POTENTIAL OPPORTUNITIES ((EMPLOYEE BENEFITS IN COMPANIES, TRADE UNIONS, FOCUS GROUPS FOR COMPANIES IN THE FOOD AND BEVERAGE SECTOR, AMONG OTHERS) 187
4.8 U.S.(STATE-BY-STATE ANALYSIS) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET, HISTORICAL EVOLUTION, AND TRENDS FOR THE FUTURE 189
5 CURRENT LEGISLATION AND POSSIBLE HEALTH REFORMS 191
5.1 GLOBAL FOOD SAFETY INITIATIVE 191
5.2 FEDERAL LEGISLATION 191
5.3 FOOD AND DRUG ADMINISTRATION (FDA) 192
5.4 TOXIC SUBSTANCES CONTROL ACT OF 1976 193
6 DOWNSTREAM END USER ANALYSIS 194
6.1 LIST OF CURRENT CUSTOMERS 194
6.2 LIST OF POTENTIAL CUSTOMERS 195
7 U.S. (STATE-BY-STATE ANALYSIS) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET, COMPANY PROFILING 196
8 MARKET OVERVIEW 198
8.1 DRIVERS 200
8.1.1 RISING CASES OF FOOD ALLERGY IN THE U.S. 200
8.1.2 FAVOURABLE GOVERNMENT POLICIES & REGULATIONS 200
8.1.3 GROWING AWARENESS AMONG THE POPULATION REGARDING FOOD ALLERGENS & FOOD INTOLERANCE 201
8.2 RESTRAINTS 201
8.2.1 HIGH INITIAL INVESTMENT FOR THE INSTALLATION OF FOOD TESTING EQUIPMENT 201
8.2.2 LACK OF AWARENESS ABOUT LABELING CONDITIONS AND REGULATIONS 201
8.3 OPPORTUNITIES 202
8.3.1 RISING TECHNICAL ADVANCEMENTS 202
8.3.2 STRATEGIC INITIATIVES TAKEN BY THE GOVERNMENT 202
8.3.3 FOOD SENSITIVITY 203
8.4 CHALLENGES 203
8.4.1 ASSOCIATED COST TO DIAGNOSE FOOD ALLERGENS AND INTOLERANCE 203
8.4.2 RISK OF FALSE NEGATIVE RESULTS 203
9 U.S. (STATE-BY-STATE) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET, BY FOOD TYPE 205
9.1 OVERVIEW 206
9.2 MILK 209
9.3 EGG 209
9.4 WHEAT AND SOY 210
9.5 TREE NUTS/SEEDS 210
9.6 PEANUTS 211
9.7 SEA FOOD 211
9.8 HERBS AND SPICES 212
9.9 FRUIT/VEGETABLES 212
9.10 BEVERAGES 213
9.11 OTHERS 214
10 U.S. (STATE-BY-STATE) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET, BY DIAGNOSIS 215
10.1 OVERVIEW 216
10.2 BLOOD TEST 220
10.3 SKIN-PRICK TEST 220
11 U.S. (STATE-BY-STATE) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET, BY DISEASE 221
11.1 OVERVIEW 222
11.2 GASTRITIS 225
11.3 SKIN DISEASE 225
11.4 ORAL ALLERGY SYNDROME 226
11.5 IRRITABLE BOWEL SYNDROME 226
11.6 MIGRAINES 226
11.7 HAIR LOSS 227
11.8 WEIGHT GAIN 227
11.9 FOOD PROTEIN-INDUCED ENTEROCOLITIS SYNDROME 228
11.10 OTHERS 228
12 U.S. (STATE-BY-STATE) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET, BY SALES CHANNEL 229
12.1 OVERVIEW 230
12.2 B2C 233
12.2.1 LOCATION 234
12.2.1.1 URBAN 234
12.2.1.2 RURAL 234
12.2.2 INCOME 234
12.2.2.1 UPPER INCOME 235
12.2.2.2 MIDDLE INCOME 235
12.2.2.3 LOWER INCOME 235
12.2.3 AGE 235
12.2.3.1 4-5 YEARS 235
12.2.3.2 0-3 YEARS 236
12.2.3.3 6-10 YEARS 236
12.2.3.4 ABOVE 60 YEARS 236
12.2.3.5 41-50 YEARS 236
12.2.3.6 51-60 YEARS 236
12.2.3.7 31-40 YEARS 236
12.2.3.8 30-40 YEARS 236
12.2.3.9 19-30 YEARS 236
12.2.3.10 11-18 YEARS 236
12.2.4 GENDER 237
12.2.4.1 FEMALE 237
12.2.4.2 MALE 237
12.3 B2B 237
12.3.1 HOSPITALS 238
12.3.2 NUTRITIONISTS 238
12.3.3 FUNCTIONAL DOCTORS 238
12.3.4 SPECIALTY CLINICS 238
12.3.5 MEDICAL SPECIALISTS 238
12.3.6 OTHERS 238
13 U.S. (STATE-BY-STATE) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET, BY DISTRIBUTION CHANNEL 239
13.1 OVERVIEW 240
13.2 RETAIL SALES 243
13.2.1 ONLINE PHARMACY 243
13.2.2 HOSPITAL PHARMACY 243
13.2.3 RETAIL PHARMACY 243
13.3 DIRECT TENDER 244
14 U.S. (STATE-BY-STATE ANALYSIS) FOOD ALLERGENS AND INTOLERANCE MARKET 245
14.1 U.S. 245
14.1.1 NEW YORK 247
14.1.2 MASSACHUSETTS 252
14.1.3 WASHINGTON 257
14.1.4 CONNECTICUT 262
14.1.5 CALIFORNIA 267
14.1.6 DELAWARE 272
14.1.7 ILLINOIS 277
14.1.8 ALASKA 282
14.1.9 MARYLAND 287
14.1.10 NORTH DAKOTA 292
14.1.11 NEW JERSEY 297
14.1.12 COLORADO 302
14.1.13 MINNESOTA 307
14.1.14 NEBRASKA 311
14.1.15 VIRGINIA 316
14.1.16 WYOMING 321
14.1.17 NEW HAMSPSHIRE 326
14.1.18 SOUTH DAKOTA 331
14.1.19 HAWAII 336
14.1.20 LOWA 341
14.1.21 PENNSYLVANIA 346
14.1.22 KANSAS 351
14.1.23 TEXAS 356
14.1.24 OREGON 361
14.1.25 UTAH 366
14.1.26 WISCONSIN 371
14.1.27 OHIO 376
14.1.28 GEORGIA 381
14.1.29 NORTH CAROLINA 386
14.1.30 INDIANA 391
14.1.31 RHODE ISLAND 396
14.1.32 NEVADA 401
14.1.33 MISSOURI 406
14.1.34 TENNESSEE 411
14.1.35 LOUISIANA 416
14.1.36 MICHIGAN 421
14.1.37 VERMONT 426
14.1.38 ARIZONA 431
14.1.39 FLORIDA 436
14.1.40 MAINE 441
14.1.41 NEW MEXICO 446
14.1.42 KENTUCKY 451
14.1.43 MONTANA 456
14.1.44 SOUTH CAROLINA 461
14.1.45 OKLAHOMA 466
14.1.46 ALABAMA 470
14.1.47 IDAHO 475
14.1.48 ARKANSAS 479
14.1.49 WEST VIRGINIA 483
14.1.50 MISSISSIPPI 487
15 U.S. (STATE-BY-STATE ANALYSIS) FOOD ALLERGENS AND INTOLERANCE TESTING MARKET: COMPANY LANDSCAPE 492
15.1 COMPANY SHARE ANALYSIS: U.S. 492
16 COMPANY PROFILE 493
16.1 QUEST DIAGNOSTICS INCORPORATED. 493
16.1.1 COMPANY SNAPSHOT 493
16.1.2 SWOT ANALYSIS 494
16.1.3 REVENUE ANALYSIS 494
16.1.4 PRODUCT PORTFOLIO 495
16.1.5 RECENT DEVELOPMENT 495
16.2 EUROFINS SCIENTIFIC 496
16.2.1 COMPANY SNAPSHOT 496
16.2.2 REVENUE ANALYSIS 496
16.2.3 SWOT ANALYSIS 497
16.2.4 PRODUCT PORTFOLIO 497
16.2.5 RECENT DEVELOPMENTS 497
16.3 CELL SCIENCE SYSTEMS 498
16.3.1 COMPANY SNAPSHOT 498
16.3.2 SWOT ANALYSIS 498
16.3.3 PRODUCT PORTFOLIO 499
16.3.4 RECENT DEVELOPMENTS 499
16.4 DSM (2022) 500
16.4.1 COMPANY SNAPSHOT 500
16.4.2 SWOT ANALYSIS 501
16.4.3 REVENUE ANALYSIS 501
16.4.4 PRODUCT PORTFOLIO 502
16.4.5 RECENT DEVELOPMENTS 502
16.5 GENOVA DIAGNOSTICS (GDX) 503
16.5.1 COMPANY SNAPSHOT 503
16.5.2 SWOT ANALYSIS 503
16.5.3 PRODUCT PORTFOLIO 504
16.5.4 RECENT DEVELOPMENTS 504

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.